Carisma Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Carisma Therapeutics generated cash of -$81,177,000, which is less than the previous year. Cash used in financing activities reached the amount of $62,180,000 last year. Net change in cash is therefore $53,411,000.
Cash Flow
| 2014 | -29.30M | -137K | 75.56M |
|---|---|---|---|
| 2015 | -34.52M | -287K | 16.83M |
| 2016 | 2.62M | 461K | -13.82M |
| 2017 | -17.76M | 98K | 7.00M |
| 2018 | -22.82M | -2K | 58.58M |
| 2019 | -37.52M | -136K | 35.35M |
| 2020 | -27.01M | -440K | 72.25M |
| 2021 | -37.32M | -1.87M | 15.96M |
| 2022 | -7.56M | -32.56M | 35.76M |
| 2023 | -81.17M | 72.40M | 62.18M |
CARM Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 24.19M | 162.63M | 51.78M | 6.98M | 50.42M | 14.69M | 25.34M | 36.07M | 54.05M | 7.94M |
Operating activities | ||||||||||
Net income | -86.87M | -61.22M | -40.78M | -28.34M | -107.5M | -33.69M | -29.02M | 1.89M | -33.45M | -34.15M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.83M | 6.09M | 682K | 448K | 219K | 208K | 285K | 178K | 366K | 410K |
Stock-based compensation expense | 2.31M | 275K | 479K | 163K | 0 | 0 | 1.38M | 4.01M | 2.52M | 2.43M |
| Deferred income tax benefit | 2.31M | 275K | 479K | 163K | 0 | 0 | 1.38M | 4.01M | 2.52M | 2.43M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 23.66M | -24.49M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | -23.66M | 24.49M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 2.19M | -473K | -974K | 1.28M | 535K | 460K | -760K | -742K | -1.21M | 1.02M |
Cash generated by operating activities | -81.17M | -7.56M | -37.32M | -27.01M | -37.52M | -22.82M | -17.76M | 2.62M | -34.52M | -29.30M |
Investing activities | ||||||||||
Purchases Of Investments | -34.46M | -90.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.13M | -4.66M | -1.87M | -440K | -136K | -2K | 0 | 0 | -287K | -137K |
Acquisitions Net | 0 | 30K | 0 | 0 | 0 | 0 | 98K | 0 | 0 | 0 |
Cash generated by investing activities | 72.40M | -32.56M | -1.87M | -440K | -136K | -2K | 98K | 461K | -287K | -137K |
Financing activities | ||||||||||
Common Stock Issued | 31.23M | 35.10M | 176.13M | 38.11M | 35.35M | 58.30M | 7.00M | 35K | 12.71M | 70.23M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -1.30M | 34.13M | 0 | 0 | 0 | 0 | 0 | -14.12M | 4.12M | -4.63M |
Cash used in financing activities | 62.18M | 35.76M | 15.96M | 72.25M | 35.35M | 58.58M | 7.00M | -13.82M | 16.83M | 75.56M |
Net Change In Cash | 53.41M | -138.44M | -23.23M | 44.80M | -2.30M | 35.75M | -10.66M | -10.73M | -17.98M | 46.11M |
Cash at end of period | 77.60M | 24.19M | 28.55M | 51.78M | 48.12M | 50.44M | 14.68M | 25.34M | 36.07M | 54.05M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |